Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis. 2004

H Pietkiewicz, and E Hiszczyńska-Sawicka, and J Kur, and E Petersen, and H V Nielsen, and M Stankiewicz, and I Andrzejewska, and P Myjak
Department of Tropical Parasitology, Interfaculty Institute of Maritime and Tropical Medicine, Medical University of Gdańsk.

Toxoplasma gondii SAG1, GRA1, and GRA7 recombinant antigens may be regarded as tools for the detection of T. gondii immunoglobulin G antibodies in persons with chronic and acute toxoplasmosis. GRA7 is more correlated with acute toxoplasmosis. A combination of these antigens will increase the sensitivity of enzyme-linked immunosorbent assays.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000913 Antibodies, Protozoan Immunoglobulins produced in a response to PROTOZOAN ANTIGENS. Protozoan Antibodies
D000953 Antigens, Protozoan Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Protozoan Antigens
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

H Pietkiewicz, and E Hiszczyńska-Sawicka, and J Kur, and E Petersen, and H V Nielsen, and M Stankiewicz, and I Andrzejewska, and P Myjak
September 2013, Clinical and vaccine immunology : CVI,
H Pietkiewicz, and E Hiszczyńska-Sawicka, and J Kur, and E Petersen, and H V Nielsen, and M Stankiewicz, and I Andrzejewska, and P Myjak
June 2006, Journal of clinical microbiology,
H Pietkiewicz, and E Hiszczyńska-Sawicka, and J Kur, and E Petersen, and H V Nielsen, and M Stankiewicz, and I Andrzejewska, and P Myjak
July 2020, Animals : an open access journal from MDPI,
H Pietkiewicz, and E Hiszczyńska-Sawicka, and J Kur, and E Petersen, and H V Nielsen, and M Stankiewicz, and I Andrzejewska, and P Myjak
August 1990, Journal of clinical microbiology,
H Pietkiewicz, and E Hiszczyńska-Sawicka, and J Kur, and E Petersen, and H V Nielsen, and M Stankiewicz, and I Andrzejewska, and P Myjak
January 2010, Polish journal of veterinary sciences,
H Pietkiewicz, and E Hiszczyńska-Sawicka, and J Kur, and E Petersen, and H V Nielsen, and M Stankiewicz, and I Andrzejewska, and P Myjak
March 2022, Diagnostic microbiology and infectious disease,
H Pietkiewicz, and E Hiszczyńska-Sawicka, and J Kur, and E Petersen, and H V Nielsen, and M Stankiewicz, and I Andrzejewska, and P Myjak
January 2022, Frontiers in cellular and infection microbiology,
H Pietkiewicz, and E Hiszczyńska-Sawicka, and J Kur, and E Petersen, and H V Nielsen, and M Stankiewicz, and I Andrzejewska, and P Myjak
May 2017, Protein expression and purification,
H Pietkiewicz, and E Hiszczyńska-Sawicka, and J Kur, and E Petersen, and H V Nielsen, and M Stankiewicz, and I Andrzejewska, and P Myjak
October 2015, Journal of medical microbiology,
H Pietkiewicz, and E Hiszczyńska-Sawicka, and J Kur, and E Petersen, and H V Nielsen, and M Stankiewicz, and I Andrzejewska, and P Myjak
July 1985, Journal of clinical & laboratory immunology,
Copied contents to your clipboard!